These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27075988)

  • 21. Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea.
    Karunajeewa HA; Reeder J; Lorry K; Dabod E; Hamzah J; Page-Sharp M; Chiswell GM; Ilett KF; Davis TM
    Antimicrob Agents Chemother; 2006 Mar; 50(3):968-74. PubMed ID: 16495259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Manual exchange transfusion for severe imported falciparum malaria: a retrospective study.
    Lin J; Huang X; Qin G; Zhang S; Sun W; Wang Y; Ren K; Xu J; Han X
    Malar J; 2018 Jan; 17(1):32. PubMed ID: 29338720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artesunate monotherapy versus artesunate plus quinine combination therapy for treatment of imported severe malaria: a TropNet retrospective cohort study.
    Botta A; Comelli A; Vellere I; Chechi F; Bianchi L; Giulia G; Tomasoni LR; Spinicci M; Galli L; Castelli F; Bartoloni A; Zammarchi L
    Infection; 2022 Aug; 50(4):949-958. PubMed ID: 35220555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study.
    Held J; Supan C; Salazar CL; Tinto H; Bonkian LN; Nahum A; Moulero B; Sié A; Coulibaly B; Sirima SB; Siribie M; Otsyula N; Otieno L; Abdallah AM; Kimutai R; Bouyou-Akotet M; Kombila M; Koiwai K; Cantalloube C; Din-Bell C; Djeriou E; Waitumbi J; Mordmüller B; Ter-Minassian D; Lell B; Kremsner PG
    Lancet Infect Dis; 2015 Dec; 15(12):1409-19. PubMed ID: 26342427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous artesunate for severe malaria.
    Prescrire Int; 2008 Aug; 17(96):168-70. PubMed ID: 19492495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artesunate to treat severe malaria in travellers: review of efficacy and safety and practical implications.
    Roussel C; Caumes E; Thellier M; Ndour PA; Buffet PA; Jauréguiberry S
    J Travel Med; 2017 Mar; 24(2):. PubMed ID: 28395097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measuring the
    Ndour PA; Larréché S; Mouri O; Argy N; Gay F; Roussel C; Jauréguiberry S; Perillaud C; Langui D; Biligui S; Chartrel N; Mérens A; Kendjo E; Ghose A; Hassan MMU; Hossain MA; Kingston HWF; Plewes K; Dondorp AM; Danis M; Houzé S; Bonnefoy S; Thellier M; Woodrow CJ; Buffet PA;
    Sci Transl Med; 2017 Jul; 9(397):. PubMed ID: 28679662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of exchange transfusion as an adjunct therapy for severe Plasmodium falciparum malaria in nonimmune travelers: a 10-year single-center experience with a standardized treatment protocol.
    van Genderen PJ; Hesselink DA; Bezemer JM; Wismans PJ; Overbosch D
    Transfusion; 2010 Apr; 50(4):787-94. PubMed ID: 19951317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous artesunate for severe malaria in travelers, Europe.
    Zoller T; Junghanss T; Kapaun A; Gjorup I; Richter J; Hugo-Persson M; Mørch K; Foroutan B; Suttorp N; Yürek S; Flick H
    Emerg Infect Dis; 2011 May; 17(5):771-7. PubMed ID: 21529383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of artesunate for the treatment of severe malaria.
    Lubell Y; Yeung S; Dondorp AM; Day NP; Nosten F; Tjitra E; Abul Faiz M; Yunus EB; Anstey NM; Mishra SK; Mohanty S; White NJ; Mills AJ
    Trop Med Int Health; 2009 Mar; 14(3):332-7. PubMed ID: 19187518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence to national guidelines for the diagnosis and management of severe malaria: a nationwide, cross-sectional survey in Malawi, 2012.
    Shah MP; Briggs-Hagen M; Chinkhumba J; Bauleni A; Chalira A; Moyo D; Dodoli W; Luhanga M; Sande J; Ali D; Gutman J; Mathanga DP; Lindblade KA
    Malar J; 2016 Jul; 15(1):369. PubMed ID: 27430311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propensity Score Analysis of Artesunate Versus Quinine for Severe Imported Plasmodium falciparum Malaria in France.
    El Ket N; Kendjo E; Thellier M; Assoumou L; Potard V; Taieb A; Tantaoui I; Caumes E; Piarroux R; Roussel C; Buffet P; Costagliola D; Jauréguiberry S
    Clin Infect Dis; 2020 Jan; 70(2):280-287. PubMed ID: 30874798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic Republic of Congo: the MATIAS study.
    Ferrari G; Ntuku HM; Burri C; Tshefu AK; Duparc S; Hugo P; Mitembo DK; Ross A; Ngwala PL; Luwawu JN; Musafiri PN; Ngoie SE; Lengeler C
    Malar J; 2015 May; 14():226. PubMed ID: 26024661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed haemolysis after artesunate treatment of severe malaria - review of the literature and perspective.
    Rolling T; Agbenyega T; Krishna S; Kremsner PG; Cramer JP
    Travel Med Infect Dis; 2015; 13(2):143-9. PubMed ID: 25812775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013.
    Jauréguiberry S; Thellier M; Ndour PA; Ader F; Roussel C; Sonneville R; Mayaux J; Matheron S; Angoulvant A; Wyplosz B; Rapp C; Pistone T; Lebrun-Vignes B; Kendjo E; Danis M; Houzé S; Bricaire F; Mazier D; Buffet P; Caumes E;
    Emerg Infect Dis; 2015 May; 21(5):804-12. PubMed ID: 25898007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous artesunate for the treatment of severe malaria.
    Hess KM; Goad JA; Arguin PM
    Ann Pharmacother; 2010; 44(7-8):1250-8. PubMed ID: 20551300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health worker perspectives on the possible use of intramuscular artesunate for the treatment of severe malaria at lower-level health facilities in settings with poor access to referral facilities in Nigeria: a qualitative study.
    Adesoro O; Shumba C; Kpamor J; Achan J; Kivumbi H; Dada J; Maxwell K; Tibenderana J; Marasciulo M; Hamade P; Oresanya O; Nankabirwa J; Baba E
    BMC Health Serv Res; 2016 Oct; 16(1):566. PubMed ID: 27729076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial.
    Sagara I; Beavogui AH; Zongo I; Soulama I; Borghini-Fuhrer I; Fofana B; Camara D; Somé AF; Coulibaly AS; Traore OB; Dara N; Kabore MJ; Thera I; Compaore YD; Sylla MM; Nikiema F; Diallo MS; Dicko A; Gil JP; Borrmann S; Duparc S; Miller RM; Doumbo OK; Shin J; Bjorkman A; Ouedraogo JB; Sirima SB; Djimdé AA
    Lancet Infect Dis; 2016 Feb; 16(2):189-98. PubMed ID: 26601738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial.
    Ramharter M; Oyakhirome S; Klein Klouwenberg P; Adégnika AA; Agnandji ST; Missinou MA; Matsiégui PB; Mordmüller B; Borrmann S; Kun JF; Lell B; Krishna S; Graninger W; Issifou S; Kremsner PG
    Clin Infect Dis; 2005 Jun; 40(12):1777-84. PubMed ID: 15909266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of severe falciparum malaria with artesunate and mefloquine.
    Chung SY; Das R; Oon CT
    Singapore Med J; 1998 May; 39(5):208-10. PubMed ID: 9713226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.